Tirzepatide, with its shorter five-day half-life, drops faster between doses
Insurance coverage may be limited or denied for non-approved indications, creating significant cost barriers as these medications can exceed $1,000 monthly without coverage
2025 FDA shipping data shows that shipments of semaglutide and tirzepatide dropped by 90 and 34 percent, respectively, from June 2024 to June 2025
Glucagon and glucagon-like peptide 1: selective receptor recognition via distinct peptide epitopes
December 2, 2025: Australian Government Issues Warning About Ozempic and Reports of Suicidality, Self-Harm The Therapeutic Goods Administration in Australia (a government agency similar to the FDA in the U.S.) warns that a concerning number of patients who take Ozempic and other GLP-1s reported suicidal ideation and self-harm
Frequently Asked Questions Can I safely skip a week of Ozempic and take it every other week instead